| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 28 | 2025 | 1035 | 3.420 |
Why?
|
| Comparative Genomic Hybridization | 22 | 2024 | 578 | 1.760 |
Why?
|
| Intellectual Disability | 16 | 2025 | 1093 | 1.710 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2025 | 1046 | 1.560 |
Why?
|
| Mosaicism | 9 | 2022 | 250 | 1.500 |
Why?
|
| Exons | 9 | 2025 | 803 | 1.450 |
Why?
|
| Chromosome Aberrations | 12 | 2024 | 591 | 1.280 |
Why?
|
| Abnormalities, Multiple | 16 | 2021 | 983 | 1.240 |
Why?
|
| Chromosome Disorders | 8 | 2019 | 312 | 1.200 |
Why?
|
| Chromosome Deletion | 11 | 2021 | 657 | 1.080 |
Why?
|
| Chromosome Duplication | 5 | 2016 | 149 | 0.990 |
Why?
|
| Genetic Diseases, Inborn | 10 | 2020 | 461 | 0.990 |
Why?
|
| Gene Deletion | 10 | 2018 | 795 | 0.910 |
Why?
|
| Phenotype | 32 | 2025 | 4545 | 0.900 |
Why?
|
| Translocation, Genetic | 7 | 2024 | 359 | 0.850 |
Why?
|
| Epilepsy | 5 | 2021 | 891 | 0.830 |
Why?
|
| Exome | 11 | 2022 | 1086 | 0.800 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 13 | 0.780 |
Why?
|
| Gene Duplication | 11 | 2025 | 371 | 0.770 |
Why?
|
| Point Mutation | 3 | 2016 | 350 | 0.740 |
Why?
|
| Microarray Analysis | 4 | 2019 | 237 | 0.730 |
Why?
|
| Calcineurin | 1 | 2021 | 62 | 0.690 |
Why?
|
| In Situ Hybridization, Fluorescence | 15 | 2022 | 775 | 0.690 |
Why?
|
| Megalencephaly | 3 | 2021 | 60 | 0.680 |
Why?
|
| INDEL Mutation | 2 | 2020 | 92 | 0.680 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2020 | 2851 | 0.670 |
Why?
|
| Trans-Activators | 7 | 2012 | 714 | 0.640 |
Why?
|
| Chromosomes, Human, Pair 17 | 9 | 2014 | 372 | 0.630 |
Why?
|
| Mutation | 11 | 2022 | 6248 | 0.580 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2018 | 2 | 0.580 |
Why?
|
| Iris Diseases | 1 | 2018 | 12 | 0.570 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 67 | 0.560 |
Why?
|
| Eye Abnormalities | 1 | 2018 | 104 | 0.540 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 947 | 0.530 |
Why?
|
| Genetic Testing | 3 | 2021 | 1098 | 0.500 |
Why?
|
| Psychomotor Disorders | 1 | 2016 | 29 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2016 | 55 | 0.500 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 50 | 0.490 |
Why?
|
| Polyhydramnios | 1 | 2016 | 56 | 0.490 |
Why?
|
| Genomics | 7 | 2025 | 1652 | 0.480 |
Why?
|
| Humans | 84 | 2025 | 132348 | 0.460 |
Why?
|
| Genetic Association Studies | 7 | 2019 | 856 | 0.460 |
Why?
|
| Haploinsufficiency | 5 | 2021 | 270 | 0.450 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 1831 | 0.440 |
Why?
|
| Single-Cell Analysis | 3 | 2019 | 353 | 0.420 |
Why?
|
| Cytogenetic Analysis | 2 | 2012 | 81 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 71 | 0.380 |
Why?
|
| Prenatal Diagnosis | 4 | 2017 | 634 | 0.380 |
Why?
|
| Membrane Proteins | 4 | 2018 | 1598 | 0.380 |
Why?
|
| Child, Preschool | 23 | 2023 | 14857 | 0.380 |
Why?
|
| Karyotyping | 5 | 2022 | 319 | 0.380 |
Why?
|
| Aneuploidy | 2 | 2014 | 144 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 11 | 2020 | 1807 | 0.370 |
Why?
|
| Syndrome | 12 | 2022 | 1171 | 0.370 |
Why?
|
| DiGeorge Syndrome | 1 | 2012 | 82 | 0.370 |
Why?
|
| Pedigree | 10 | 2021 | 1725 | 0.370 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 27 | 0.360 |
Why?
|
| Gene Dosage | 8 | 2013 | 449 | 0.350 |
Why?
|
| Genome, Human | 9 | 2025 | 1332 | 0.350 |
Why?
|
| Facies | 5 | 2017 | 156 | 0.340 |
Why?
|
| Female | 48 | 2025 | 70795 | 0.320 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2009 | 258 | 0.320 |
Why?
|
| Craniofacial Abnormalities | 5 | 2016 | 254 | 0.320 |
Why?
|
| Developmental Disabilities | 6 | 2025 | 749 | 0.310 |
Why?
|
| Heterozygote | 6 | 2018 | 717 | 0.310 |
Why?
|
| Male | 40 | 2024 | 65061 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2024 | 121 | 0.310 |
Why?
|
| Child | 23 | 2025 | 25827 | 0.300 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2025 | 378 | 0.300 |
Why?
|
| Trisomy | 3 | 2021 | 112 | 0.290 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 94 | 0.290 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2009 | 94 | 0.290 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2022 | 215 | 0.290 |
Why?
|
| Amniotic Fluid | 2 | 2012 | 154 | 0.290 |
Why?
|
| Heart Defects, Congenital | 4 | 2024 | 1867 | 0.290 |
Why?
|
| Alleles | 7 | 2019 | 1683 | 0.280 |
Why?
|
| Autistic Disorder | 3 | 2022 | 387 | 0.280 |
Why?
|
| Language Development Disorders | 3 | 2019 | 179 | 0.280 |
Why?
|
| Germ Cells | 2 | 2022 | 204 | 0.280 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2024 | 551 | 0.270 |
Why?
|
| Homozygote | 4 | 2019 | 548 | 0.270 |
Why?
|
| Crossing Over, Genetic | 2 | 2003 | 55 | 0.260 |
Why?
|
| Genotyping Techniques | 3 | 2016 | 110 | 0.260 |
Why?
|
| Sequence Deletion | 4 | 2016 | 527 | 0.250 |
Why?
|
| Carrier Proteins | 4 | 2025 | 1049 | 0.250 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 182 | 0.250 |
Why?
|
| Base Sequence | 8 | 2022 | 2904 | 0.240 |
Why?
|
| Transcription Factors | 6 | 2022 | 2494 | 0.240 |
Why?
|
| Congenital Abnormalities | 2 | 2021 | 300 | 0.240 |
Why?
|
| Brain | 4 | 2016 | 3198 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 623 | 0.220 |
Why?
|
| Inheritance Patterns | 4 | 2020 | 131 | 0.220 |
Why?
|
| Genetic Variation | 6 | 2019 | 1583 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 61 | 0.220 |
Why?
|
| Amniocentesis | 4 | 2017 | 77 | 0.220 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 4695 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 1019 | 0.210 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2023 | 7 | 0.210 |
Why?
|
| Charcot-Marie-Tooth Disease | 3 | 2020 | 239 | 0.210 |
Why?
|
| Heterotaxy Syndrome | 1 | 2024 | 63 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2014 | 142 | 0.210 |
Why?
|
| Synteny | 2 | 2004 | 77 | 0.200 |
Why?
|
| Chromosome Mapping | 6 | 2016 | 1098 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 3358 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 3 | 2022 | 282 | 0.200 |
Why?
|
| Mutation, Missense | 4 | 2021 | 938 | 0.200 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 135 | 0.190 |
Why?
|
| Infant | 16 | 2021 | 13195 | 0.190 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 3780 | 0.190 |
Why?
|
| DNA | 5 | 2022 | 1484 | 0.190 |
Why?
|
| Chaperonins | 1 | 2002 | 15 | 0.190 |
Why?
|
| Adolescent | 16 | 2021 | 20553 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 82 | 0.190 |
Why?
|
| Proton-Translocating ATPases | 1 | 2002 | 18 | 0.190 |
Why?
|
| Esophageal Atresia | 1 | 2022 | 52 | 0.190 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2022 | 48 | 0.190 |
Why?
|
| DNA Mutational Analysis | 3 | 2016 | 825 | 0.180 |
Why?
|
| Animals | 18 | 2024 | 34995 | 0.180 |
Why?
|
| Penetrance | 3 | 2007 | 113 | 0.180 |
Why?
|
| Micrognathism | 1 | 2021 | 67 | 0.180 |
Why?
|
| Proteins | 2 | 2019 | 1064 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 212 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2022 | 248 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 201 | 0.170 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 259 | 0.170 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2020 | 6 | 0.160 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 410 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2022 | 208 | 0.160 |
Why?
|
| Microcephaly | 2 | 2021 | 354 | 0.160 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2020 | 20 | 0.160 |
Why?
|
| Failure to Thrive | 2 | 2021 | 93 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 273 | 0.160 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 23 | 0.160 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 1997 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2018 | 1010 | 0.160 |
Why?
|
| Limit of Detection | 1 | 2019 | 77 | 0.150 |
Why?
|
| Atrophy | 1 | 2019 | 253 | 0.150 |
Why?
|
| Mice | 14 | 2022 | 18572 | 0.150 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 81 | 0.150 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 7 | 0.150 |
Why?
|
| Obesity | 3 | 2012 | 2406 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 61 | 0.150 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 7 | 0.150 |
Why?
|
| Chorionic Villi Sampling | 3 | 2017 | 46 | 0.150 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 26 | 0.150 |
Why?
|
| Trophoblasts | 1 | 2019 | 121 | 0.150 |
Why?
|
| Homologous Recombination | 2 | 2022 | 100 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
| Physical Examination | 2 | 2016 | 166 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 406 | 0.140 |
Why?
|
| Problem Behavior | 1 | 2019 | 41 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 72 | 0.140 |
Why?
|
| Pediatric Obesity | 1 | 2023 | 411 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 68 | 0.140 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 235 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 544 | 0.140 |
Why?
|
| Limb Deformities, Congenital | 2 | 2011 | 112 | 0.140 |
Why?
|
| Genetic Markers | 1 | 2019 | 619 | 0.140 |
Why?
|
| Lysosomes | 1 | 2019 | 262 | 0.140 |
Why?
|
| Seizures | 3 | 2021 | 895 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 508 | 0.130 |
Why?
|
| DNA Replication | 2 | 2016 | 353 | 0.130 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2017 | 61 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.130 |
Why?
|
| Congenital Hypothyroidism | 1 | 2016 | 10 | 0.130 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2016 | 29 | 0.130 |
Why?
|
| Neutropenia | 1 | 2018 | 205 | 0.130 |
Why?
|
| Computational Biology | 2 | 2017 | 875 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 114 | 0.130 |
Why?
|
| Troponin T | 1 | 2018 | 295 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 38 | 0.130 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2016 | 8 | 0.130 |
Why?
|
| Gene Expression | 1 | 2021 | 1564 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 454 | 0.130 |
Why?
|
| Chromosome Inversion | 1 | 2016 | 77 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1556 | 0.130 |
Why?
|
| Chromosome Banding | 2 | 2014 | 140 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2022 | 17364 | 0.120 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 71 | 0.120 |
Why?
|
| Prader-Willi Syndrome | 2 | 2017 | 71 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 513 | 0.120 |
Why?
|
| Pregnancy | 6 | 2019 | 7567 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 542 | 0.120 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2014 | 106 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 2 | 2019 | 430 | 0.110 |
Why?
|
| Chromosomes, Human, X | 2 | 2017 | 158 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2019 | 800 | 0.110 |
Why?
|
| Fetus | 1 | 2018 | 599 | 0.110 |
Why?
|
| Cell Line | 4 | 2016 | 2730 | 0.110 |
Why?
|
| Frameshift Mutation | 2 | 2006 | 201 | 0.110 |
Why?
|
| Gametogenesis | 1 | 2014 | 25 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 686 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1068 | 0.110 |
Why?
|
| Software | 1 | 2019 | 729 | 0.110 |
Why?
|
| Genotype | 3 | 2016 | 2706 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 466 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 94 | 0.100 |
Why?
|
| Down Syndrome | 2 | 2017 | 230 | 0.100 |
Why?
|
| Adult | 12 | 2021 | 31619 | 0.100 |
Why?
|
| Young Adult | 8 | 2021 | 9945 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 182 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 764 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2012 | 102 | 0.100 |
Why?
|
| Genes, Recessive | 1 | 2013 | 195 | 0.100 |
Why?
|
| Uniparental Disomy | 1 | 2012 | 42 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 309 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 368 | 0.090 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 90 | 0.090 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2011 | 13 | 0.090 |
Why?
|
| Infant, Newborn | 7 | 2022 | 8568 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 148 | 0.090 |
Why?
|
| Williams Syndrome | 1 | 2012 | 42 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 93 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2014 | 330 | 0.090 |
Why?
|
| Fanconi Anemia | 1 | 2011 | 39 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2673 | 0.090 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 200 | 0.090 |
Why?
|
| Genetic Counseling | 3 | 2021 | 246 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1526 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2012 | 365 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 303 | 0.080 |
Why?
|
| Fibroblasts | 3 | 2019 | 879 | 0.080 |
Why?
|
| Genome | 3 | 2007 | 502 | 0.080 |
Why?
|
| Models, Genetic | 3 | 2014 | 771 | 0.080 |
Why?
|
| Sex Chromosomes | 1 | 2009 | 32 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 6 | 2012 | 4767 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 328 | 0.080 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2009 | 14 | 0.080 |
Why?
|
| DNA Repair | 1 | 2011 | 567 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1132 | 0.070 |
Why?
|
| Gene Order | 2 | 2011 | 82 | 0.070 |
Why?
|
| Genetic Engineering | 2 | 2007 | 164 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3062 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 2453 | 0.070 |
Why?
|
| Chromosome Breakage | 3 | 2011 | 158 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 37 | 0.060 |
Why?
|
| Chromosomes | 2 | 2007 | 139 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 43 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2145 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 460 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2006 | 109 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1722 | 0.060 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2006 | 38 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2009 | 879 | 0.060 |
Why?
|
| Contig Mapping | 2 | 2002 | 54 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2008 | 826 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2019 | 3873 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2007 | 284 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2004 | 253 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2004 | 75 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2018 | 751 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2005 | 174 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2004 | 122 | 0.050 |
Why?
|
| Syntaxin 16 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2018 | 377 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2023 | 16 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 383 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2004 | 144 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2018 | 5150 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2003 | 180 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 295 | 0.050 |
Why?
|
| Chromogranins | 1 | 2023 | 28 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 454 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2003 | 215 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2006 | 507 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2023 | 46 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1723 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 430 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 221 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 637 | 0.050 |
Why?
|
| Siblings | 1 | 2023 | 202 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2005 | 301 | 0.050 |
Why?
|
| Chromosomes, Artificial, P1 Bacteriophage | 1 | 2002 | 6 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 89 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 57 | 0.050 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2002 | 26 | 0.050 |
Why?
|
| Pseudogenes | 1 | 2002 | 51 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 1285 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 33 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2007 | 906 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 92 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 49 | 0.050 |
Why?
|
| Segmental Duplications, Genomic | 2 | 2012 | 81 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2002 | 136 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 350 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 173 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 804 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2002 | 357 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 305 | 0.040 |
Why?
|
| Chromatin | 1 | 2004 | 521 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2021 | 150 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 150 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1426 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 338 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2303 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 411 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 151 | 0.040 |
Why?
|
| Base Composition | 2 | 2013 | 74 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 698 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 45 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 56 | 0.040 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2017 | 4 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 47 | 0.030 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2017 | 15 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 142 | 0.030 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2017 | 19 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2017 | 21 | 0.030 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2017 | 16 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2017 | 62 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 2017 | 45 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 699 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2021 | 409 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 81 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 2017 | 72 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2023 | 1132 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 100 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 2946 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 3629 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 464 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 420 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 198 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 252 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2011 | 617 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 327 | 0.030 |
Why?
|
| Dwarfism | 1 | 2016 | 104 | 0.030 |
Why?
|
| Body Weight | 2 | 2012 | 1006 | 0.030 |
Why?
|
| Family | 1 | 2018 | 595 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 408 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 615 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 64 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 578 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 573 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 841 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 565 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 48 | 0.030 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 56 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 1076 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 744 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2013 | 251 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1454 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 17 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 763 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1042 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 687 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 452 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1378 | 0.020 |
Why?
|
| Receptors, Glycine | 1 | 2011 | 17 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 236 | 0.020 |
Why?
|
| Anal Canal | 1 | 2011 | 82 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 392 | 0.020 |
Why?
|
| Spine | 1 | 2011 | 146 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 540 | 0.020 |
Why?
|
| Chromosome Breakpoints | 1 | 2010 | 83 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 500 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1458 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 255 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2004 | 927 | 0.020 |
Why?
|
| Trachea | 1 | 2011 | 210 | 0.020 |
Why?
|
| Esophagus | 1 | 2011 | 234 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5010 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 242 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 93 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3023 | 0.020 |
Why?
|
| Social Dominance | 1 | 2006 | 11 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 156 | 0.010 |
Why?
|
| Introns | 1 | 2006 | 304 | 0.010 |
Why?
|
| Leptin | 1 | 2006 | 219 | 0.010 |
Why?
|
| Kidney | 1 | 2011 | 1331 | 0.010 |
Why?
|
| Retroviridae | 1 | 2004 | 194 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 378 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 6540 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 355 | 0.010 |
Why?
|
| Learning | 1 | 2006 | 370 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2003 | 269 | 0.010 |
Why?
|
| Retina | 1 | 2006 | 492 | 0.010 |
Why?
|
| Meiosis | 1 | 2002 | 116 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3853 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 161 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2002 | 109 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 447 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 262 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 236 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 1211 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 545 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 813 | 0.010 |
Why?
|
| Anxiety | 1 | 2006 | 1002 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 732 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1261 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 1816 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6456 | 0.010 |
Why?
|